ADC Analytical Method Development & Validation

Antibody-drug conjugates (ADCs) combine antibodies, linkers, and highly potent payloads, creating complex analytical requirements across development and manufacturing. Reliable analytical methods are essential for evaluating ADC identity, purity, conjugation characteristics, drug-to-antibody ratio (DAR), impurities, and other critical quality attributes (CQAs).

Protheragen provides ADC analytical method development and validation services covering method development, optimization, qualification or validation, and analytical method transfer. Analytical strategies can be tailored to the ADC format, development stage, target quality attributes, and intended application, supporting process development, formulation development, stability studies, and manufacturing activities.

Overview of ADC Analytical Method Development & Validation

ADC analytical method development is an iterative process that establishes fit-for-purpose analytical procedures for monitoring product quality throughout development. Because ADCs contain multiple structural components and may exhibit heterogeneity in conjugation, charge, molecular size, and payload distribution, analytical methods need to be selected and optimized according to the specific characteristics of each molecule.

The analytical development process may cover methods for identity, purity, molecular size, charge heterogeneity, conjugation characteristics, DAR, free payload, residual components, and other product-related attributes. As the program advances, selected methods can be further optimized, qualified or validated, and transferred for routine testing or manufacturing support.

Fig.1 Mechanism of action of an ADC and subsequent quantification by different bioanalytical platforms. (Khan, R.M.N., et al., 2025)

Our Services

ADC Analytical Methods & Quality Attributes

ADC analytical methods are selected based on the molecule, development stage, and intended application. Typical analytical approaches include:

The final analytical panel should be established based on the ADC molecule and its identified CQAs rather than applying a fixed analytical package to every program.

Method Development & Validation Parameters

Depending on the analytical method and intended use, method performance may be assessed through:

• Specificity – Ability to distinguish the target analyte from related substances, impurities, degradation products, or matrix components.
• Accuracy – Assessment of the closeness of measured results to the expected or reference value.
• Precision – Evaluation of repeatability and intermediate precision under defined conditions.
• Linearity & Range – Establishment of an appropriate relationship between analytical response and analyte concentration.
• Detection & Quantitation Capability – Evaluation of sensitivity where applicable to the analytical purpose.
• Robustness – Assessment of method performance following controlled variations in critical analytical parameters.
• System Suitability – Definition of appropriate system-performance criteria to ensure reliable analytical runs.

The final validation or qualification package is tailored to the method type, intended use, development stage, and applicable regulatory expectations.

Applications of ADC Analytical Method Development

Process and analytical development strategies can be adapted to different ADC development scenarios, including:

• Supporting ADC Process Development

Analytical methods provide quantitative and qualitative information for monitoring conjugation reactions, purification performance, DAR distribution, free payload, molecular-size variants, and other process-related attributes.

• Supporting Formulation Development

Analytical procedures can be applied to evaluate formulation-dependent changes in aggregation, fragmentation, charge heterogeneity, concentration, DAR, and other relevant product attributes.

• Supporting Stability Studies

Fit-for-purpose analytical methods help monitor changes in ADC quality during storage and under stress conditions, providing data for degradation pathway assessment and formulation or process optimization.

• Supporting Manufacturing & Scale-Up

Established analytical procedures can support batch characterization, process monitoring, manufacturing scale-up, and analytical consistency during technology transfer.

• Supporting Regulatory Development

Appropriately developed and qualified or validated analytical methods can generate reliable analytical data for development reports, CMC documentation, and regulatory submissions, according to the intended use of each method.

Why Choose Protheragen

• Integrated ADC Analytical Strategy

Analytical method development is coordinated with ADC process development, formulation development, characterization, and stability activities, helping maintain analytical continuity throughout the development program.

• ADC-Specific Method Development

Analytical approaches are selected and optimized according to the complex characteristics of ADC molecules, including conjugation heterogeneity, DAR distribution, molecular-size variants, charge variants, and payload-related impurities.

• Flexible Fit-for-Purpose Approach

The analytical strategy can be adjusted according to development stage, analytical objective, molecule characteristics, and intended application, avoiding unnecessary analytical complexity during early development while supporting appropriate qualification or validation at later stages.

• Development-to-Transfer Continuity

Methods developed during early-stage research can be progressively optimized, qualified or validated, documented, and transferred to support later-stage development and manufacturing activities.

• Complementary Analytical Capabilities

Analytical method development can be integrated with structural characterization, stability studies, and comparability assessment, providing a connected analytical framework for ADC development.

ADC analytical method development requires an integrated understanding of molecular structure, conjugation chemistry, product heterogeneity, and intended analytical use. By combining method development, optimization, qualification or validation, and transfer, Protheragen supports the establishment of reliable analytical procedures for ADC development and manufacturing. Analytical methods can be tailored to specific ADC quality attributes and development objectives, providing a practical foundation for process optimization, formulation development, stability evaluation, quality assessment, and later-stage manufacturing activities. Contact us to discuss your ADC analytical method development and validation requirements and develop a fit-for-purpose analytical strategy for your program.